Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (461-470 of 777) with videos related to

Pageof 78
Sort By:
Advances in Medical Sciences|March 10, 2022
Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertensionPhilipp Schwabl, Berit Anna Seeland, Florian Riedl, et al.
Gut|April 12, 2018
Colesevelam attenuates cholestatic liver and bile duct injury in <i>Mdr2</i> mice by modulating composition, signalling and excretion of faecal bile acidsClaudia Daniela Fuchs, Gustav Paumgartner, Veronika Mlitz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 17, 2020
Recent outbreaks of severe hepatitis A virus infections in ViennaDavid Bauer, Anna Farthofer, David Chromy, et al.
Hepatology Communications|January 16, 2026
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytesLaura Valestrand, Kathrine S Nordhus, Thierry Claudel, et al.
AIDS (London, England)|January 14, 2016
Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver diseaseMattias Mandorfer, Philipp Schwabl, Sebastian Steiner, et al.
Plos One|February 4, 2016
Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering EffectGerd Hörl, Harald Froehlich, Ulrika Ferstl, et al.
Wiener Klinische Wochenschrift|January 9, 2020
Portal hypertensive gastropathy is associated with iron deficiency anemiaBenedikt Simbrunner, Andrea Beer, Katharina Wöran, et al.
United European Gastroenterology Journal|March 25, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care centerMathias Jachs, Raphael Sauberer, Alexander Stiegler, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2023
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppressionMathias Jachs, Marlene Panzer, Lukas Hartl, et al.
Oncotarget|November 30, 2016
Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver diseaseUrsula J Lemberger, Claudia D Fuchs, Matthias Karer, et al.
Pageof 78

Showing results (461-470 of 777) with videos related to

Sort By:
Pageof 78
Advances in Medical Sciences|March 10, 2022
Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertensionPhilipp Schwabl, Berit Anna Seeland, Florian Riedl, et al.
Gut|April 12, 2018
Colesevelam attenuates cholestatic liver and bile duct injury in <i>Mdr2</i> mice by modulating composition, signalling and excretion of faecal bile acidsClaudia Daniela Fuchs, Gustav Paumgartner, Veronika Mlitz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 17, 2020
Recent outbreaks of severe hepatitis A virus infections in ViennaDavid Bauer, Anna Farthofer, David Chromy, et al.
Hepatology Communications|January 16, 2026
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytesLaura Valestrand, Kathrine S Nordhus, Thierry Claudel, et al.
AIDS (London, England)|January 14, 2016
Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver diseaseMattias Mandorfer, Philipp Schwabl, Sebastian Steiner, et al.
Plos One|February 4, 2016
Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering EffectGerd Hörl, Harald Froehlich, Ulrika Ferstl, et al.
Wiener Klinische Wochenschrift|January 9, 2020
Portal hypertensive gastropathy is associated with iron deficiency anemiaBenedikt Simbrunner, Andrea Beer, Katharina Wöran, et al.
United European Gastroenterology Journal|March 25, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care centerMathias Jachs, Raphael Sauberer, Alexander Stiegler, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2023
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppressionMathias Jachs, Marlene Panzer, Lukas Hartl, et al.
Oncotarget|November 30, 2016
Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver diseaseUrsula J Lemberger, Claudia D Fuchs, Matthias Karer, et al.
Pageof 78